QKI and cancer: The observation that genes alternatively spliced by QKI during EMT and in cancer are also frequently members of the actin cytoskeleton network identifies a novel convergence of miR‐200 function, whereby it controls both alternative splicing of this network (indirectly, via QKI) and gene expression (directly, via 3′UTR targeting).